Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.

Yuan S, Xiao B, Ni S, Liu W, Hou M, Jiang Y, Jia L

Open source

DOI
10.1186/s12967-026-08742-6
Published
2026 Aug 3
Container
Journal of translational medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-026-08742-6,
  title = {Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.},
  author = {Yuan S and Xiao B and Ni S and Liu W and Hou M and Jiang Y and Jia L},
  year = {2026},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-026-08742-6},
  url = {https://doi.org/10.1186/s12967-026-08742-6}
}

RIS

TY  - JOUR
TI  - Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.
AU  - Yuan S
AU  - Xiao B
AU  - Ni S
AU  - Liu W
AU  - Hou M
AU  - Jiang Y
AU  - Jia L
PY  - 2026
JO  - Journal of translational medicine
DO  - 10.1186/s12967-026-08742-6
UR  - https://doi.org/10.1186/s12967-026-08742-6
ER  - 

APA

S, Y., B, X., S, N., W, L., M, H., Y, J., & L, J. (2026). Acetoacetate-GPR43 axis epigenetically silences IL-6/CSF1 to restrict TAMs-driven metastatic lung cancer.. Journal of translational medicine. https://doi.org/10.1186/s12967-026-08742-6

Source records